Abstract
Intercellular communication is pivotal in optimizing and synchronizing cellular responses to keep homeostasis and to respond adequately to external stimuli. In the central nervous system (CNS), glutamatergic and GABAergic signals are postulated to be dependent on the glutamate/GABA-glutamine cycle for vesicular loading of neurotransmitters, for inactivating the signal and for the replenishment of the neurotransmitters. Islets of Langerhans release the hormones insulin and glucagon, but share similarities with CNS cells in for example transcriptional control of development and differentiation, and chromatin methylation. Interestingly, CNS proteins involved in secretion of the neurotransmitters and emitting their responses as well as the regulation of these processes, are also found in islet cells. Moreover, high levels of glutamate, GABA, and glutamine and their respective vesicular and plasma membrane transporters have been shown in the islet cells and there is emerging support for these amino acids and their transporters playing important roles in the maturation and secretion of insulin and glucagon. In this review, we will discuss the feasibility of recent data in the field in relation to the biophysical properties of the transporters (Slc1, Slc17, Slc32, and Slc38) and physiology of hormone secretion in islets of Langerhans.
Introduction
The endocrine cells of the pancreas and the cells of nervous system have different functions but also reveal interesting similarities. Islet cells of Langerhans secrete insulin and glucagon and are considered to be necessary for maintaining glucose homeostasis. However, neurons may also release insulin, and compelling evidence have been provided for a brain-centered glucoregulatory system that work in concert with the islet cells to regulate plasma levels of glucose (1–3). Interestingly, recent advances in the field reveal mechanistic similarities in the regulation of insulin and glucagon secretion in the islets as compared to neurotransmitter release. Amino acids, which play pivotal roles in fast neuronal signaling, have also been proposed to act as signaling molecules in the islets of Langerhans (4–7). This is consistent with the detection of significant changes in plasma glutamine concentrations in newly diagnosed diabetic patients (8) indicating that dysfunctional amino acid metabolism, signaling, and/or amino acid transporter function may precede and/or augment development of diabetes. In this review, we will discuss the significance of glutamate, GABA, and glutamine and their transporters in the regulation of insulin and glucagon secretion in the pancreas.
Amino acid transporters and neuronal signaling
Classical neuronal signaling is a form of paracrine signaling where a neurotransmitter is released at the synapse from a neuron and the message is conveyed by activation of specific receptors on the surface of an adjacent neuron. Several amino acids play fundamental roles in synaptic transmission. Glutamate and GABA are the main fast excitatory and inhibitory neurotransmitters, respectively. After their release, the signal is partly inactivated by transport of the released neurotransmitter into astroglial cells and conversion to glutamine catalyzed by glutamine synthetase (GS) (9, 10). Glutamine may then be released from astroglial processes and shuttled back to neurons for regeneration of the transmitters by the neuronal phosphate-activated glutaminase (PAG) (11, 12). Existence of such a cycle, known as the glutamate/GABA-glutamine (GGG) cycle, is bolstered by the demonstration of glutamate and GABA transporters on synaptic vesicles and on perisynaptic astroglial plasma membranes (13–17), and by the characterization of the Slc38 family of amino acid (glutamine) transporters (18–20). We have demonstrated that the Slc38 family members SN1 (Slc38a3) and SN2 (Slc38a5) release glutamine from the astrocytes (18, 21, 22), while SAT2 (Slc38a2) imports glutamine into glutamatergic neurons and maintains neurotransmitter pools of glutamate involved in retrograde signaling (23). The Slc38 family member SAT1 (Slc38a1) is selectively localized in inhibitory neurons supporting uptake of glutamine for GABA formation (19, 24). Consistent with a role of SAT1 in the GGG cycle, the SAT inhibitor MeAIB reduces GABAergic inhibitory synaptic transmission (25, 26). However, the presence of these transporters also in peripheral organs suggests important roles in cell-specific metabolism and/or in non-neuronal signaling (27–29).
The endocrine cells of the islets of Langerhans harbor proteins involved in classical neuronal signaling
The endocrine cells of the pancreas share many characteristics with the cells of the central nervous system (CNS). The two tissues share a similar transcription program (30) and have extensive similarities in global mRNA expression and chromatin methylation (31). In addition, transcription factors like Pax6 and Nkx6.1 are important for development and differentiation of both neurons and islet cells (32–34).
The endocrine islet cells also contain most of the components involved in synaptic transmission in the CNS. In addition to the hormone loaded secretory granules (SGs), islet cells contain synaptic-like microvesicles (SLMVs) resembling synaptic vesicles found in nerve terminals (35, 36). The exocytosis of SGs and SLMVs also share many similarities with the exocytosis of synaptic vesicles. As in the CNS, exocytosis is dependent on the opening of voltage-dependent Ca2+ channels (37, 38), and on the complex assembly of SNARE proteins including SNAP25 and syntaxin coupled to the vesicle and to the target membrane (39). Furthermore, exocytosis and hormone secretion is in both regulated by myotrophin, and the same miRNA, miR-375, regulates translation of its gene in both tissues (40). In addition, the biogenesis of SLMVs in β-cells is dependent on the same adaptor protein complex as in GABAergic neurons (41).
There is co-release of glucagon and glutamate from α-cells (42), and SLMVs of β-cells contain high levels of glutamate (43). In β-cells, glutamate activation of AMPA and kainate receptors stimulates Ca2+ influx and insulin secretion (44, 45), whereas mGluR stimulation, both inhibit and stimulate insulin secretion depending on the concentration of glucose (46, 47). In addition, glutamate stimulates GABA release from SLMVs in β-cells independently of insulin release (48). In α-cells, glutamate inhibits glucagon secretion. Thus, glutamate is involved in both paracrine and autocrine regulation of glucagon and insulin.
When it comes to GABAergic signaling, GABAA receptor activation is important for β-cell autocrine feedback (49), and it reduces glucagon secretion from α-cells (50, 51). Furthermore, the key enzymes involved in the metabolism of the neurotransmitters glutamate and GABA, e.g., PAG, glutamic acid decarboxylase (GAD), and GS, are all present in islet cells (4, 52, 53). In fact, islet β-cells contain GABA and GAD at the same levels as GABAergic neurons (54, 55), and β-cells have the highest GABA concentration outside the CNS.
Glucose and amino acids in the regulation of insulin secretion
The main triggering signal for insulin release from β-cells is elevated plasma glucose levels. When plasma glucose levels rise postprandially, facilitated transport by the low affinity glucose transporter GLUT2 (Km = 15–20 mM), the primary glucose transporter present on β-cells (56), is initiated (Figure 1). In β-cells, glucose is metabolized through the TCA cycle to yield ATP, the main stimulator of insulin secretion (37). ATP acts by closing potassium channels which leads to depolarization of the β-cell (37). Exocytosis of insulin containing SGs occurs when Ca2+ levels rise after opening of voltage-gated Ca2+-channels (37, 38).
Figure 1
Many amplifying signals modify islet secretion (57). There is support for amino acids influencing the endocrine function of the pancreas (4–6), and in particular glutamate, GABA, and glutamine are postulated to play a role in the regulation of hormone secretion (4, 7). Deletion of glutamate dehydrogenase (GDH), which catalyzes the conversion between glutamate and the TCA cycle intermediate α-ketoglutarate, decreases glucose-induced insulin secretion by approximately 40% (58). In addition, glutamine’s ability to evoke insulin release is decreased in isolated islets from GDH knockouts (59). Furthermore, the very close proximity between the different cell types in human islets facilitates flux of substrates and paracrine signaling for the orchestration of islet secretion (Figure 1) (60, 61). Thus, there are compelling evidence for glutamate, GABA, and glutamine being involved in regulating islet hormone secretion.
Amino Acid Transporters in Islet Secretion
As described above, glutamate and GABA, their specific receptors and effects, as well as the enzymes involved in their metabolism have all been shown in the islet. However, the mechanisms involved in the transport of amino acids across plasma and vesicle membranes and mode of action in the islet cells are poorly understood. Interestingly, recent advances in the characterization of amino acid transporters in the islets reveal peculiar insight into novel mechanisms for signaling in the islets.
Vesicular glutamate and GABA transporters are localized on SLMVs as well as SGs in islet cells
Glutamate is transported into synaptic vesicles by the vesicular glutamate transporters (VGLUT1-3) of the Slc17 family (62), whereas VGAT (Slc32) transports the inhibitory neurotransmitters GABA and glycine (63, 64). In the CNS, the VGLUTs and VGAT may be localized on different subsets of synaptic vesicles or co-localized on the same vesicles (65–68). This differential localization of vesicular transporters allows for co-release or differential release of transmitters, as well as concerted action to increase packaging.
Islet cells express both VGLUTs and VGAT (Figure 1). In α-cells, VGLUT1 and VGLUT2 are found on glucagon containing SGs (43, 69), supporting the finding that there is co-release of glucagon and glutamate from α-cells (42). On the SLMVs of the α-cells, there is expression of the 57-kDa isoform of VGAT found in the CNS (55, 70–72), but in addition a novel 52.5 kDa isoform is found on the SGs (72). The expression levels of the 52.5-kDa VGAT isoform increase with increasing glucose levels, opposite to the regulation of the transcription and activity of VGLUT1 and VGLUT2 which is down-regulated by increasing glucose levels in islet cell cultures (73). Thus, granular loading of glutamate, GABA, and glycine changes with changing glycemic conditions, allowing for fine-tuning of hormone secretion.
In the β-cells, VGLUT3 is found on both SGs and SLMVs (Figure 1A) (43). However, the SGs contain little glutamate (43), and direct stimulation of granule secretion with sulfonylurea tolbutamide, which closes ATP-sensitive potassium channels, does not lead to glutamate release from β-cells (74), questioning the role of SG release of glutamate as important for signaling. Unlike β-cell SGs, SLMVs accumulate glutamate and express high levels of VGLUT3 (43). It has been hypothesized that the main function of SLMV exocytosis is to supply the plasma membrane with the proteins and lipids necessary to withstand the stress from substances like Zn2+ secreted together with insulin (75). However, the presence of VGLUT3 on and glutamate in SLMVs might indicate that glutamate release from β-cells participates in feedback mechanisms regulating insulin secretion. This is supported by the fact that exocytosis of SLMVs and SGs is differentially regulated through two cAMP-dependent pathways (75). β-cells also express the 57-kDa isoform of VGAT on SLMVs (55, 71, 72), which probably primarily supports GABA release, as β-cells contain much higher levels of GABA compared to glycine (55).
Thus, both islet SGs and SLMVs have the machinery necessary to load them with glutamate and/or GABA and glycine, which can then be released in an exocytotic manner.
Plasma membrane glutamate transporters may terminate fast transmission as well as contribute to a novel mechanism for the maturation of SGs
Na+-dependent glutamate transport across the cell membrane in islet cells (76), probably facilitated by the glutamate transporter GLT/EAAT2 (Slc1) expressed on the plasma membrane of pancreatic β-cells (77), can terminate glutamate signaling (Figure 1A). In fact, glutamate transport by EAAT2 prevents glutamate induced excitotoxicity as down-regulation of EAAT2 lead to increased β-cell death, whereas up-regulation increased β-cell survival (77).
EAAT2 has also been shown to be strongly expressed on the membrane of SGs in β-cells (43), and co-localizes with both chromogranin, a neuroendocrine secretory protein in granules, and insulin in β-cells (77). As discussed above, the SGs also express VGLUT3, but there is very little concomitant release of glutamate and insulin (74) and glutamate levels inside SGs are insignificant (43). The presence of both of these transporters in the β-cells raises the possibility of alternative mechanisms through which glutamate can act as an intracellular signaling molecule modulating the release of insulin.
Gammelsæter and co-workers postulated that glutamate transport might participate in the maturation of insulin in the SGs, and thus the regulation of insulin release (43). SGs contain a vesicular H+-ATPase which pumps protons into the SGs (Figure 1B). Uptake of negatively charged glutamate by VGLUT3 sets up a counter-charge movement which decreases the granular membrane polarization allowing sustained transport by the H+-ATPase. If glutamate leaves the SGs through EAAT2, three positively charged sodium ions and a proton will be exported, while one potassium ion will enter the SG. Thus, there will be a net export of positive charge, further counteracting inhibition of the H+-ATPase, allowing for further acidification of the SG. Acidification is crucial for the conversion of pro-insulin to active insulin (78, 79), and it is thought to be important for the exocytotic process (79). Interestingly, perturbation of the granular acidification by genetic deletion of the chloride channel ClC-3, which resides on the SGs (Figure 1B), also results in abolished insulin release (80). Chloride ions also regulate or penetrate VGLUTs and VGAT (81, 82), and may acidify SG in multiple ways. Altogether, these data suggest that VGLUT3 probably works in consortium with EAAT2 to acidify the SGs through glutamate import and subsequent export, which further regulates the level of insulin released upon glucose stimulation.
Members of the Slc38 family of amino acid transporters might both supply glutamine for the formation of glutamate and GABA and contribute to plasma membrane depolarization in the islets of Langerhans
The islets of Langerhans express transcripts for several members of the Slc38 gene family (Figures 1A and 2) (83). Immunofluorescence co-labeling with antibodies against SN1 and SAT2 with specific markers for the different cell populations of the islets showed SN1 at the plasma membrane of β-cells, whereas SAT2 was found on the membrane of α-cells. This distribution resembles the complementary expression pattern of SAT2 and SN1 in the CNS, where SN1 and SAT2 transport glutamine from astrocytes to glutamatergic neurons for the replenishment of glutamate (23).
Figure 2
SN1 translocates glutamine coupled to a symport of Na+ (18). In addition, it is sensitive to pH, and SN1 both transports protons coupled to the transport of glutamine and allows for flux of protons not stoichiometrically dependent on the movement of substrate (21, 84, 85). Under most physiological conditions, the electroneutral SN1 may therefore transport glutamine bidirectionally (18, 21, 84–87). SN1 at the membrane of β-cells might therefore accumulate glutamine for glutamate and GABA synthesis (Figures 1A and 2), but at different feeding status it may contribute to the release of glutamine (Figure 2), as discussed below.
Glutamine has been shown to have a profound effect on insulin secretion (4–6). Increased levels of glutamate and GABA in β-cells from replenishment by glutamine are not sufficient to explain this strong effect on secretion. It is therefore likely that glutamine contributes to the regulation of insulin secretion through additional mechanisms. First, glutamine taken up by SN1 might stimulate insulin secretion through the conversion of glutamine to glutamate by PAG (Figure 1A), which is present in β-cells (53). This is in agreement with earlier findings showing conversion of glutamine to glutamate in islet cells (88, 89). In the β-cell, glutamate can then enter the TCA cycle through the action of GDH, and stimulate insulin secretion in the same -dependent way as glucose (53). This is supported by the fact that, in isolated islets from GDH knockouts there is an abrogation of insulin release evoked by glutamine (59). Alternatively, glutamate flux through VGLUT3 and EAAT2 on SGs might contribute to the maturation of insulin, as described above (Figure 1B). Glutamine transport by SN1 can also contribute to the depolarization of the membrane of β-cells. As already mentioned SN1 is sodium dependent and exhibits a channel-like activity, for e.g., protons, inducing inward currents (18, 21, 85). Due to these characteristics, SN1 can have a depolarizing effect upon transport of glutamine (21). The potassium channel is responsible for the depolarization initiated insulin release in response to glucose. In knockout mice with a loss of function mutation of the , insulin secretion can be triggered by amino acids (4). This effect decreased 60% if glutamine was omitted, which was suggested to be due to the depolarizing effect of glutamine transport into the cell (4), and the conveyer may well be SN1 (83). Thus, glutamine uptake by SN1 due to elevated serum levels of glutamine may not only stimulate insulin secretion through conversion to glutamate, but also by amplifying the depolarization of the plasma membrane.
Lack of coupling to proton translocation enables the SATs to utilize both the electrical and the chemical gradients of sodium, creating higher glutamine concentration gradients compared to SN1 (19, 23, 90). In addition, SAT2 has higher affinity for glutamine than SN1 (90). According to our findings, SAT2 is expressed on α-cells (Figures 1A and 2) (83). In α-cells, glutamate is exocytosed together with glucagon when blood glucose levels are low (42). As SAT2 is able to create a large concentration gradient of glutamine across the membrane, SAT2 might therefore ensure a constant supply of glutamine for the production of glutamate. Interestingly, when the interprandial serum levels of glutamine are low, flux reversal of SN1 might assure substrate for transport by SAT2 (Figure 2). Since system A transport depolarizes cells (19, 90), its activity might also stimulate glucagon secretion in a similar manner to the postulated role of SN1 in β-cell depolarization.
All in all, as SN1 changes direction of transport at glutamine concentrations well within physiological fluctuations in amino acid content of the blood (18), SN1 might be a convenient conveyer of plasma amino acid level stimuli for islet cell secretion. We have therefore proposed that SN1 works as a sensor of nutritional status (83). When the blood glutamine concentration is high it may mediate uptake of glutamine in β-cells. However, when blood glutamine concentration decreases between meals it may mediate release from β-cells. This will promote the ability of SAT2 to import glutamine into α-cells and thus stimulate glucagon secretion (Figure 2). Furthermore, insulin has been shown to regulate SN1 expression and function (28), allowing for possible additional feedback mechanisms.
Conclusion
The main components of synaptic transmission are present in the islet cells implicating similarities in signaling pathways. This notion is further reinforced by the fact that human neural progenitor cells may be differentiated to produce insulin (1). In the CNS, synaptic transmission is based on a tripartite synapse where the perisynaptic astroglial cells actively participate in fine-tuning and termination of the signal and in supplying precursors for the neurotransmitters. An analog to the tripartite synapse does not exist in the islets of Langerhans. However, secretion by the different islet cells is regulated by both paracrine and autocrine signaling, which again depends on glutamate and GABA. Moreover, the amino acid transporters involved in the GGG cycle in the CNS do have the corresponding and necessary localizations to support glutamine-mediated synthesis of glutamate and GABA, their exocytotic release and termination of the signal in the islets of Langerhans. Depolarization of the plasma membrane due to inward transport by SN1 upon elevated plasma glutamine concentration and/or its metabolism to glutamate and ATP might be important regulators of insulin secretion after protein rich meals. Similarly, glutamine from plasma or from β-cells upon reversed action of SN1 may activate SAT2 on α-cells (Figure 2). Such glutamine transport may depolarize α-cells and/or glutamine may be metabolized to glutamate to regulate glucagon secretion. This resembles the situation in the CNS where glutamine uptake through SAT1 depolarizes the nerve terminal and regulate transmitter release (19). The co-localization of EAAT2 and VGLUT3 on insulin containing SGs supports a cell-specific flux of glutamate through the granules, which may facilitate the acidification necessary for insulin maturation prior to secretion. Thus, there are several striking similarities, but there are also important differences in the functional roles of the amino acid transporters in these two tissues. Altogether, our data suggest that in addition to insulin secretion in the islets of Langerhans and the brain-centered glucoregulatory system (3), amino acid metabolism and amino acid transporters might also be potential therapeutic targets in diabetes.
Statements
Author contributions
This review was written by Monica Jenstad and Farrukh Abbas Chaudhry in collaboration.
Acknowledgments
We would like to thank Gunnar Lothe for technical assistance in preparing the figures. This work has been supported by The Norwegian Diabetes Association, Johan Selmer Kvanes Endowment, and The Research Council of Norway.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1
HoriYGuXXieXKimSK. Differentiation of insulin-producing cells from human neural progenitor cells. PLoS Med (2005) 2:e103.10.1371/journal.pmed.0020103
2
WangSTulinaNCarlinDLRulifsonEJ. The origin of islet-like cells in Drosophila identifies parallels to the vertebrate endocrine axis. Proc Natl Acad Sci U S A (2007) 104:19873–8.10.1073/pnas.0707465104
3
SchwartzMWSeeleyRJTschopMHWoodsSCMortonGJMyersMGet alCooperation between brain and islet in glucose homeostasis and diabetes. Nature (2013) 503:59–66.10.1038/nature12709
4
LiCBuettgerCKwaghJMatterADaikhinYNissimIBet alA signaling role of glutamine in insulin secretion. J Biol Chem (2004) 279:13393–401.10.1074/jbc.M311502200
5
GaoZYLiGNajafiHWolfBAMatschinskyFM. Glucose regulation of glutaminolysis and its role in insulin secretion. Diabetes (1999) 48:1535–42.10.2337/diabetes.48.8.1535
6
ZawalichWSYamazakiHZawalichKCClineG. Comparative effects of amino acids and glucose on insulin secretion from isolated rat or mouse islets. J Endocrinol (2004) 183:309–19.10.1677/joe.1.05832
7
MaechlerPWollheimCB. Mitochondrial glutamate acts as a messenger in glucose-induced insulin exocytosis. Nature (1999) 402:685–9.10.1038/45280
8
NewsholmePBrennanLRubiBMaechlerP. New insights into amino acid metabolism, β-cell function and diabetes. Clin Sci (2005) 108:185–94.10.1042/CS20040290
9
Martínez-HernandezABellKPNorenbergMD. Glutamine synthetase: glial localization in brain. Science (1977) 195:1356–8.10.1126/science.14400
10
HaberleJShahbeckNIbrahimKSchmittBScheerIO’GormanRet alGlutamine supplementation in a child with inherited GS deficiency improves the clinical status and partially corrects the peripheral and central amino acid imbalance. Orphanet J Rare Dis (2012) 7:48.10.1186/1750-1172-7-48
11
KvammeETorgnerIARobergB. Kinetics and localization of brain phosphate activated glutaminase. J Neurosci Res (2001) 66:951–8.10.1002/jnr.10041
12
ChaudhryFABoullandJLJenstadMBredahlMKEdwardsRH. Pharmacology of neurotransmitter transport into secretory vesicles. Handb Exp Pharmacol (2008) 184:77–106.10.1007/978-3-540-74805-2_4
13
ChaudhryFALehreKPvan LookerenCMOttersenOPDanboltNCStorm-MathisenJ. Glutamate transporters in glial plasma membranes: highly differentiated localizations revealed by quantitative ultrastructural immunocytochemistry. Neuron (1995) 15:711–20.10.1016/0896-6273(95)90158-2
14
ChaudhryFAReimerRJBellocchioEEDanboltNCOsenKKEdwardsRHet alThe vesicular GABA transporter, VGAT, localizes to synaptic vesicles in sets of glycinergic as well as GABAergic neurons. J Neurosci (1998) 18:9733–50.
15
FremeauRTJrTroyerMDPahnerINygaardGOTranCHReimerRJet alThe expression of vesicular glutamate transporters defines two classes of excitatory synapse. Neuron (2001) 31:247–60.10.1016/S0896-6273(01)00344-0
16
BoullandJLQureshiTSealRPRafikiAGundersenVBergersenLHet alExpression of the vesicular glutamate transporters during development indicates the widespread corelease of multiple neurotransmitters. J Comp Neurol (2004) 480:264–80.10.1002/cne.20354
17
RowleyNMMadsenKKSchousboeASteve WhiteH. Glutamate and GABA synthesis, release, transport and metabolism as targets for seizure control. Neurochem Int (2012) 61:546–58.10.1016/j.neuint.2012.02.013
18
ChaudhryFAReimerRJKrizajDBarberDStorm-MathisenJCopenhagenDRet alMolecular analysis of system N suggests novel physiological roles in nitrogen metabolism and synaptic transmission. Cell (1999) 99:769–80.10.1016/S0092-8674(00)81674-8
19
ChaudhryFASchmitzDReimerRJLarssonPGrayATNicollRet alGlutamine uptake by neurons: interaction of protons with system A transporters. J Neurosci (2002) 22:62–72.
20
AlbrechtJSidoryk-WegrzynowiczMZielinskaMAschnerM. Roles of glutamine in neurotransmission. Neuron Glia Biol (2010) 6:263–76.10.1017/S1740925X11000093
21
ChaudhryFAKrizajDLarssonPReimerRJWredenCStorm-MathisenJet alCoupled and uncoupled proton movement by amino acid transport system N. EMBO J (2001) 20:7041–51.10.1093/emboj/20.24.7041
22
HamdaniEHGudbrandsenMBjørkmoMChaudhryFA. The system N transporter SN2 doubles as a transmitter precursor furnisher and a potential regulator of NMDA receptors. Glia (2012) 60:1671–83.10.1002/glia.22386
23
JenstadMQuaziAZZilberterMHaglerødCBerghuisPSaddiqueNet alSystem A transporter SAT2 mediates replenishment of dendritic glutamate pools controlling retrograde signaling by glutamate. Cereb Cortex (2009) 19:1092–106.10.1093/cercor/bhn151
24
SolbuTTBjørkmoMBerghuisPHarkanyTChaudhryFA. SAT1, a glutamine transporter, is preferentially expressed in GABAergic neurons. Front Neuroanat (2010) 4:1.10.3389/neuro.05.001.2010
25
LiangSLCarlsonGCCoulterDA. Dynamic regulation of synaptic GABA release by the glutamate-glutamine cycle in hippocampal area CA1. J Neurosci (2006) 26:8537–48.10.1523/JNEUROSCI.0329-06.2006
26
FrickeMNJones-DavisDMMathewsGC. Glutamine uptake by system A transporters maintains neurotransmitter GABA synthesis and inhibitory synaptic transmission. J Neurochem (2007) 102:1895–904.10.1111/j.1471-4159.2007.04649.x
27
SolbuTTBoullandJLZahidWLyamouri BredahlMKAmiry-MoghaddamMStorm-MathisenJet alInduction and targeting of the glutamine transporter SN1 to the basolateral membranes of cortical kidney tubule cells during chronic metabolic acidosis suggest a role in pH regulation. J Am Soc Nephrol (2005) 16:869–77.10.1681/ASN.2004060433
28
GuSVillegasCJJiangJX. Differential regulation of amino acid transporter SNAT3 by insulin in hepatocytes. J Biol Chem (2005) 280:26055–62.10.1074/jbc.M504401200
29
BröerS. The SLC38 family of sodium-amino acid co-transporters. Pflugers Arch (2013).10.1007/s00424-013-1393-y. [Epub ahead of print].
30
ArntfieldMEvan der KooyD. β-Cell evolution: how the pancreas borrowed from the brain: the shared toolbox of genes expressed by neural and pancreatic endocrine cells may reflect their evolutionary relationship. Bioessays (2011) 33:582–7.10.1002/bies.201100015
31
van ArensbergenJGarcía-HurtadoJMoranIMaestroMAXuXVan de CasteeleMet alDerepression of polycomb targets during pancreatic organogenesis allows insulin-producing beta-cells to adopt a neural gene activity program. Genome Res (2010) 20:722–32.10.1101/gr.101709.109
32
XieQYangYHuangJNinkovicJWalcherTWolfLet alPax6 interactions with chromatin and identification of its novel direct target genes in lens and forebrain. PLoS One (2013) 8:e54507.10.1371/journal.pone.0054507
33
JensenJ. Gene regulatory factors in pancreatic development. Dev Dyn (2004) 229:176–200.10.1002/dvdy.10460
34
MüllerMJabsNLorkeDEFritzschBSanderM. Nkx6.1 controls migration and axon pathfinding of cranial branchio-motoneurons. Development (2003) 130:5815–26.10.1242/dev.00815
35
Ahnert-HilgerGStadtbaumerAStrubingCScherublHSchultzGRieckenEOet alγ-Aminobutyric acid secretion from pancreatic neuroendocrine cells. Gastroenterology (1996) 110:1595–604.10.1053/gast.1996.v110.pm8613067
36
Thomas-ReetzACDe CamilliP. A role for synaptic vesicles in non-neuronal cells: clues from pancreatic β cells and from chromaffin cells. FASEB J (1994) 8:209–16.
37
MacDonaldPEWheelerMB. Voltage-dependent K+ channels in pancreatic beta cells: role, regulation and potential as therapeutic targets. Diabetologia (2003) 46:1046–62.10.1007/s00125-003-1159-8
38
ProksPLippiatJD. Membrane ion channels and diabetes. Curr Pharm Des (2006) 12:485–501.10.2174/138161206775474431
39
LeungYMKwanEPNgBKangYGaisanoHY. SNAREing voltage-gated K+ and ATP-sensitive K+ channels: tuning β-cell excitability with syntaxin-1A and other exocytotic proteins. Endocr Rev (2007) 28:653–63.10.1210/er.2007-0010
40
BaroukhNNVan ObberghenE. Function of microRNA-375 and microRNA-124a in pancreas and brain. FEBS J (2009) 276:6509–21.10.1111/j.1742-4658.2009.07353.x
41
SuckowATCraigeBFaundezVCainWJChesslerSD. An AP-3-dependent mechanism drives synaptic-like microvesicle biogenesis in pancreatic islet β-cells. Am J Physiol Endocrinol Metab (2010) 299:E23–32.10.1152/ajpendo.00664.2009
42
HayashiMYamadaHUeharaSMorimotoRMuroyamaAYatsushiroSet alSecretory granule-mediated co-secretion of L-glutamate and glucagon triggers glutamatergic signal transmission in islets of Langerhans. J Biol Chem (2003) 278:1966–74.10.1074/jbc.M206758200
43
GammelsæterRCoppolaTMarcaggiPStorm-MathisenJChaudhryFAAttwellDet alA role for glutamate transporters in the regulation of insulin secretion. PLoS One (2011) 6:e22960.10.1371/journal.pone.0022960
44
GonoiTMizunoNInagakiNKuromiHSeinoYMiyazakiJet alFunctional neuronal ionotropic glutamate receptors are expressed in the non-neuronal cell line MIN6. J Biol Chem (1994) 269:16989–92.
45
MorleyPMacLeanSGendronTFSmallDLTremblayRDurkinJPet alPharmacological and molecular characterization of glutamate receptors in the MIN6 pancreatic beta-cell line. Neurol Res (2000) 22:379–85.
46
BriceNLVaradiAAshcroftSJMolnarE. Metabotropic glutamate and GABAB receptors contribute to the modulation of glucose-stimulated insulin secretion in pancreatic beta cells. Diabetologia (2002) 45:242–52.10.1007/s00125-001-0750-0
47
CabreraOJacques-SilvaMCSpeierSYangSNKohlerMFachadoAet alGlutamate is a positive autocrine signal for glucagon release. Cell Metab (2008) 7:545–54.10.1016/j.cmet.2008.03.004
48
BraunMWendtABirnirBBromanJEliassonLGalvanovskisJet alRegulated exocytosis of GABA-containing synaptic-like microvesicles in pancreatic β-cells. J Gen Physiol (2004) 123:191–204.10.1085/jgp.200308966
49
BraunMRamracheyaRBengtssonMClarkAWalkerJNJohnsonPRet alγ-Aminobutyric acid (GABA) is an autocrine excitatory transmitter in human pancreatic β-cells. Diabetes (2010) 59:1694–701.10.2337/db09-0797
50
RorsmanPBerggrenPOBokvistKEricsonHMöhlerHÖstensonCGet alGlucose-inhibition of glucagon secretion involves activation of GABAA-receptor chloride channels. Nature (1989) 341:233–6.10.1038/341233a0
51
XuEKumarMZhangYJuWObataTZhangNet alIntra-islet insulin suppresses glucagon release via GABA-GABAA receptor system. Cell Metab (2006) 3:47–58.10.1016/j.cmet.2005.11.015
52
KimJRichterWAanstootHJShiYFuQRajotteRet alDifferential expression of GAD65 and GAD67 in human, rat, and mouse pancreatic islets. Diabetes (1993) 42:1799–808.10.2337/diab.42.12.1799
53
AnnoTUeharaSKatagiriHOhtaYUedaKMizuguchiHet alOverexpression of constitutively activated glutamate dehydrogenase induces insulin secretion through enhanced glutamate oxidation. Am J Physiol Endocrinol Metab (2004) 286:E280–5.10.1152/ajpendo.00380.2003
54
GarryDJSorensonRLCoulterHD. Ultrastructural localization of gamma amino butyric acid immunoreactivity in B cells of the rat pancreas. Diabetologia (1987) 30:115–9.
55
GammelsæterRFroylandMAragónCDanboltNCFortinDStorm-MathisenJet alGlycine, GABA and their transporters in pancreatic islets of Langerhans: evidence for a paracrine transmitter interplay. J Cell Sci (2004) 117:3749–58.10.1242/jcs.01209
56
ThorensBSarkarHKKabackHRLodishHF. Cloning and functional expression in bacteria of a novel glucose transporter present in liver, intestine, kidney, and β-pancreatic islet cells. Cell (1988) 55:281–90.10.1016/0092-8674(88)90051-7
57
MaechlerP. Mitochondrial function and insulin secretion. Mol Cell Endocrinol (2013) 379:12–8.10.1016/j.mce.2013.06.019
58
CarobbioSFrigerioFRubiBVetterliLBloksgaardMGjinovciAet alDeletion of glutamate dehydrogenase in β-cells abolishes part of the insulin secretory response not required for glucose homeostasis. J Biol Chem (2009) 284:921–9.10.1074/jbc.M806295200
59
VetterliLCarobbioSPournourmohammadiSMartin-Del-RioRSkyttDMWaagepetersenHSet alDelineation of glutamate pathways and secretory responses in pancreatic islets with β-cell-specific abrogation of the glutamate dehydrogenase. Mol Biol Cell (2012) 23:3851–62.10.1091/mbc.E11-08-0676
60
BarkerCJLeibigerIBBerggrenPO. The pancreatic islet as a signaling hub. Adv Biol Regul (2013) 53:156–63.10.1016/j.jbior.2012.09.011
61
CaicedoA. Paracrine and autocrine interactions in the human islet: more than meets the eye. Semin Cell Dev Biol (2013) 24:11–21.10.1016/j.semcdb.2012.09.007
62
HnaskoTSEdwardsRH. Neurotransmitter corelease: mechanism and physiological role. Annu Rev Physiol (2012) 74:225–43.10.1146/annurev-physiol-020911-153315
63
McIntireSLReimerRJSchuskeKEdwardsRHJorgensenEM. Identification and characterization of the vesicular GABA transporter. Nature (1997) 389:870–6.10.1038/39908
64
JonasPBischofbergerJSandkühlerJ. Corelease of two fast neurotransmitters at a central synapse. Science (1998) 281:419–24.10.1126/science.281.5375.419
65
ChaudhryFAEdwardsRHFonnumF. Vesicular neurotransmitter transporters as targets for endogenous and exogenous toxic substances. Annu Rev Pharmacol Toxicol (2008) 48:277–301.10.1146/annurev.pharmtox.46.120604.141146
66
BoullandJLJenstadMBoekelAJWouterloodFGEdwardsRHStorm-MathisenJet alVesicular glutamate and GABA transporters sort to distinct sets of vesicles in a population of presynaptic terminals. Cereb Cortex (2009) 19:241–8.10.1093/cercor/bhn077
67
StensrudMJChaudhryFALeergaardTBBjaalieJGGundersenV. Vesicular glutamate transporter-3 in the rodent brain: vesicular colocalization with vesicular γ-aminobutyric acid transporter. J Comp Neurol (2013) 521:3042–56.10.1002/cne.23331
68
El MestikawySWallén-MackenzieAFortinGMDescarriesLTrudeauLE. From glutamate co-release to vesicular synergy: vesicular glutamate transporters. Nat Rev Neurosci (2011) 12:204–16.10.1038/nrn2969
69
HayashiMMorimotoRYamamotoAMoriyamaY. Expression and localization of vesicular glutamate transporters in pancreatic islets, upper gastrointestinal tract, and testis. J Histochem Cytochem (2003) 51:1375–90.10.1177/002215540305101014
70
HayashiMOtsukaMMorimotoRMuroyamaAUeharaSYamamotoAet alVesicular inhibitory amino acid transporter is present in glucagon-containing secretory granules in αTC6 cells, mouse clonal α-cells, and α-cells of islets of Langerhans. Diabetes (2003) 52:2066–74.10.2337/diabetes.52.8.2066
71
ChesslerSDSimonsonWTSweetIRHammerleLP. Expression of the vesicular inhibitory amino acid transporter in pancreatic islet cells: distribution of the transporter within rat islets. Diabetes (2002) 51:1763–71.10.2337/diabetes.51.6.1763
72
SuckowATSweetIRVan YserlooBRutledgeEAHallTRWaldropMet alIdentification and characterization of a novel isoform of the vesicular γ-aminobutyric acid transporter with glucose-regulated expression in rat islets. J Mol Endocrinol (2006) 36:187–99.10.1677/jme.1.01866
73
BaiLZhangXGhishanFK. Characterization of vesicular glutamate transporter in pancreatic α- and β-cells and its regulation by glucose. Am J Physiol Gastrointest Liver Physiol (2003) 284:G808–14.10.1152/ajpgi.00333.2002
74
FeldmannNdel RioRMGjinovciATamarit-RodriguezJWollheimCBWiederkehrA. Reduction of plasma membrane glutamate transport potentiates insulin but not glucagon secretion in pancreatic islet cells. Mol Cell Endocrinol (2011) 338:46–57.10.1016/j.mce.2011.02.019
75
HatakeyamaHTakahashiNKishimotoTNemotoTKasaiH. Two cAMP-dependent pathways differentially regulate exocytosis of large dense-core and small vesicles in mouse β-cells. J Physiol (2007) 582:1087–98.10.1113/jphysiol.2007.135228
76
WeaverCDGundersenVVerdoornTA. A high affinity glutamate/aspartate transport system in pancreatic islets of Langerhans modulates glucose-stimulated insulin secretion. J Biol Chem (1998) 273:1647–53.10.1074/jbc.273.3.1647
77
Di CairanoESDavalliAMPeregoLSalaSSacchiVFLaRSet alThe glial glutamate transporter 1 (GLT1) is expressed by pancreatic β-cells and prevents glutamate-induced β-cell death. J Biol Chem (2011) 286:14007–18.10.1074/jbc.M110.183517
78
OrciLRavazzolaMAmherdtMMadsenOPerreletAVassalliJDet alConversion of proinsulin to insulin occurs coordinately with acidification of maturing secretory vesicles. J Cell Biol (1986) 103:2273–81.10.1083/jcb.103.6.2273
79
BargSHuangPEliassonLNelsonDJObermüllerSRorsmanPet alPriming of insulin granules for exocytosis by granular Cl- uptake and acidification. J Cell Sci (2001) 114:2145–54.
80
DeriyLVGomezEAJacobsonDAWangXHopsonJALiuXYet alThe granular chloride channel ClC-3 is permissive for insulin secretion. Cell Metab (2009) 10:316–23.10.1016/j.cmet.2009.08.012
81
JugeNMuroyamaAHiasaMOmoteHMoriyamaY. Vesicular inhibitory amino acid transporter is a Cl-/γ-aminobutyrate co-transporter. J Biol Chem (2009) 284:35073–8.10.1074/jbc.M109.062414
82
OmoteHMiyajiTJugeNMoriyamaY. Vesicular neurotransmitter transporter: bioenergetics and regulation of glutamate transport. Biochemistry (2011) 50:5558–65.10.1021/bi200567k
83
GammelsæterRJenstadMBredahlMKGundersenVChaudhryFA. Complementary expression of SN1 and SAT2 in the islets of Langerhans suggests concerted action of glutamine transport in the regulation of insulin secretion. Biochem Biophys Res Commun (2009) 381:378–82.10.1016/j.bbrc.2009.02.062
84
BröerAAlbersASetiawanIEdwardsRHChaudhryFALangFet alRegulation of the glutamine transporter SN1 by extracellular pH and intracellular sodium ions. J Physiol (2002) 539:3–14.10.1113/jphysiol.2001.013303
85
SchneiderHPBröerSBröerADeitmerJW. Heterologous expression of the glutamine transporter SNAT3 in Xenopus oocytes is associated with four modes of uncoupled transport. J Biol Chem (2007) 282:3788–98.10.1074/jbc.M609452200
86
GuSRoderickHLCamachoPJiangJX. Identification and characterization of an amino acid transporter expressed differentially in liver. Proc Natl Acad Sci U S A (2000) 97:3230–5.10.1073/pnas.97.7.3230
87
Nissen-MeyerLSPopescuMCHamdaniEHChaudhryFA. Protein kinase C-mediated phosphorylation of a single serine residue on the rat glial glutamine transporter SN1 governs its membrane trafficking. J Neurosci (2011) 31:6565–75.10.1523/JNEUROSCI.3694-10.2011
88
MalaisseWJSenerACarpinelliARAnjaneyuluKLebrunPHerchuelzAet alThe stimulus-secretion coupling of glucose-induced insulin release. XLVI. Physiological role of L-glutamine as a fuel for pancreatic islets. Mol Cell Endocrinol (1980) 20:171–89.10.1016/0303-7207(80)90080-5
89
BrocaCBrennanLPetitPNewsholmePMaechlerP. Mitochondria-derived glutamate at the interplay between branched-chain amino acid and glucose-induced insulin secretion. FEBS Lett (2003) 545:167–72.10.1016/S0014-5793(03)00526-X
90
ReimerRJChaudhryFAGrayATEdwardsRH. Amino acid transport system A resembles system N in sequence but differs in mechanism. Proc Natl Acad Sci U S A (2000) 97:7715–20.10.1073/pnas.140152797
Summary
Keywords
GABA, glutamate, glutamine, insulin, SAT2, Slc38a2, Slc38a3, SN1
Citation
Jenstad M and Chaudhry FA (2013) The Amino Acid Transporters of the Glutamate/GABA-Glutamine Cycle and Their Impact on Insulin and Glucagon Secretion. Front. Endocrinol. 4:199. doi: 10.3389/fendo.2013.00199
Received
25 September 2013
Accepted
16 December 2013
Published
31 December 2013
Volume
4 - 2013
Edited by
Leif Hertz, China Medical University, China
Reviewed by
Leif Hertz, China Medical University, China; Michael Byrne Robinson, University of Pennsylvania, USA
Copyright
© 2013 Jenstad and Chaudhry.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Monica Jenstad, Institute for Medical Informatics, Oslo University Hospital, Radiumhospitalet, PO Box 4953 Nydalen, Oslo NO-0424, Norway e-mail: mjenstad@gmail.com
This article was submitted to Cellular Endocrinology, a section of the journal Frontiers in Endocrinology.
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.